Famed cannabis breeding and lifestyle company DNA Genetics has partnered up with Israel-based medical cannabis company UNIVO Pharmaceuticals UNVO to bring its products to the Israeli medical cannabis market.
The plan is to bring DNA Genetics’ vast catalogue of high-quality strains to Israel and develop medical and science-based cannabis products using UNIVO’s advanced farming infrastructure to aid consumers in Israel and the world.
“UNIVO Pharmaceuticals is the perfect partner for DNA Genetics as we expand into the Israeli medical cannabis market. By introducing our world-class genetics to Israel, we can continue to develop additional medicinal cannabis products overseas and help the world realize the potential of cannabis for overall health and well-being,” Rezwan Khan, president of DNA Genetics, told Benzinga.
Details on the deal will follow soon.
Encuentra nuestro contenido en Español en El Planteo:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.